Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy

Methods in Enzymology

Volumn 493, Issue , 2011, Pages 469-485

  Maurer, Till ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD; PROTEIN;

ARTICLE; AUTOMATION; BINDING AFFINITY; BINDING SITE; HUMAN; LIGAND BINDING; MOLECULAR DOCKING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TARGETING; X RAY CRYSTALLOGRAPHY;

EID: 79952375115     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381274-2.00018-2     Document Type: Chapter

References (18)

1. M. Brüggert, T. Rehm, S. Shanker, S. Georgescu, and T.A. Holak A novel medium for expression of proteins selectively labeled with 15 N-amino acids in Spodoptera frugiperda (Sf9) insect cells J. Biomol. NMR 25 4 2003 335 348 (Pubitemid 36546600)
2. G. Bodenhausen, and D.J. Rubin Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy Chen. Phys. Lett. 69 1980 185 189
3. A. Chen, and M.J. Shapiro NOE pumping. 2. A high-throughput method to determine compounds with binding affinity to macromolecules by NMR J. Am. Chem. Soc. 122 2 2000 414 415 (Pubitemid 30061083)
4. G. Chessari, and A.J. Woodhead From fragment to clinical candidate: A historical perspective Drug Discov. Today 14 13-14 2009 668 675
5. C. Dalvit NMR methods in fragment screening: Theory and a comparison with other biophysical techniques Drug Discov. Today 14 21-22 2009 1051 1057
6. A. De Marco, R.A. Laursen, and M. Llinas 1 H-NMR spectroscopic manifestations of ligand binding to the kringle 4 domain of human plasminogen Arch. Biochem. Biophys. 244 1986 727 741 (Pubitemid 16053056)
7. D. Gonzlez-Ruiz, and H. Gohlke Steering protein-ligand docking with quantitative NMR chemical shift perturbations J. Chem. Inf. Model 49 10 2009 2260 2271
8. P.J. Hajduk, E.T. Olejniczak, and S.W. Fesik One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules J. Am. Chem. Soc. 119 1997 12257 12261 (Pubitemid 28078713)
9. V. Jayalakshmi, and N.R. Krishna Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes J. Magn. Reson. 155 1 2002 106 118
10. S.R. LaPlante, D.R. Cameron, N. Aubry, S. Lefebvre, G. Kukolj, R. Maurice, D. Thibeault, D. Lamarre, and M. Llins-Brunet Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain J. Biol. Chem. 274 26 1999 18618 18624
11. M. Mayer, and B. Meyer Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor J. Am. Chem. Soc. 123 25 2001 6108 6117 (Pubitemid 32888480)
12. MOEv2007.09. Developed and distributed by Chemical Computing Group. http://www.chemcomp.com
13. K. Pervushin, R. Riek, G. Wider, and K. Wuthrich Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution Proc. Natl. Acad. Sci. USA 94 1997 12366 12371
14. F.H. Schumann, H. Riepl, T. Maurer, W. Gronwald, K.P. Neidig, and H.R. Kalbitzer Combined chemical shift changes and amino acid specific chemical shift mapping of protein-protein interactions J. Biomol. NMR 39 4 2007 275 289 (Pubitemid 350055750)
15. S.B. Shuker, P.J. Hajduk, R.P. Meadows, and S.W. Fesik Discovering high-affinity ligands for proteins: SAR by NMR Science 274 5292 1996 1531 1534 (Pubitemid 26403929)
16. M.G. Szczepina, R.B. Zheng, G.C. Completo, T.L. Lowary, and B.M. Pinto STD-NMR studies suggest that two acceptor substrates for GlfT2, a bifunctional galactofuranosyltransferase required for the biosynthesis of Mycobacterium tuberculosis arabinogalactan, compete for the same binding site Chembiochem 10 12 2009 2052 2059
17. TECAN Journal Edition 2, 2009
18. A.J. Woodhead, H. Angove, M.G. Carr, G. Chessari, M. Congreve, J.E. Coyle, J. Cosme, B. Graham, P.J. Day, R. Downham, L. Fazal, and R. Feltell Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl) -1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug design J. Med. Chem. 53 2010 5956 5969